Bioresorbable Scaffold-Based Controlled Drug Delivery for Restenosis

Tesfamariam, B

Tesfamariam, B (reprint author), US FDA, Div Cardiovasc & Renal Prod, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,Bldg 22,Rm 4176, Silver Spring, MD 20993 USA.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2019; 12 (3): 193

Abstract

Bioresorbable scaffolds have emerged as a potential alternative to non-erodible metal implants to alleviate the long-term risk of permanent device vas......

Full Text Link